Market News - Page 645

GSK announces positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) for patients with ovarian cancer in the first line maintenance setting…

Grainger completes on forward funding of a 216 home PRS development at Fabrik in Leeds for c.£34m…

Ahead of its AGM later today, Palace Capital, the Main Market listed property investment company that has a diversified portfolio of UK regional commercial real estate in carefully selected locations outside of London, provides the following short update on its Hudson Quarter development in York:…

On 3 July 2019, the board of CBRE Group, Inc. (“CBRE”) and Telford Homes Plc (“Telford Homes”) announced that they had reached agreement on the terms of a recommended cash acquisition of the entire issued and to be issued share capital of Telford Homes by CBRE (or at CBRE's election, one or more direct or indirect wholly-owned subsidiaries of CBRE), (the “Acquisition”)….

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Imfinzi (durvalumab) for the treatment of small cell lung cancer (SCLC)….

Genetics breakthrough to increase resistance to Streptococcus iniae in tilapia, addresses one of the biggest challenges in the world's second most farmed species….

Scapa commences legal action against ConvaTec…

Somero is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday 4 September 2019….